Table 1.
Relationship between Dnmt1 and pathological change in patients with gastric cancer (case number, %)
| Subtotal |
Dnmt1 transcription |
P | |||
| Up-regulated | Normal | Down-regulated | |||
| Total or subtotal | 28 (100.0) | 9 (32.14) | 9 (32.14) | 10 (35.72) | |
| Age (yr) > 50 | 18 (64.30) | 7 (38.89) | 4 (22.22) | 7 (38.89) | 0.30 |
| < 50 | 10 (35.70) | 2 (20.00) | 5 (50.00) | 3 (30.00) | |
| Size of tumor >5 cm | 14 (50.00) | 4 (28.57) | 5 (35.71) | 5 (35.71) | 0.88 |
| <5 cm | 14 (50.00) | 4 (28.57) | 5 (35.71) | 5 (35.71) | |
| Borrmann II | 6 (21.43) | 2 (33.33) | 0 (0.00) | 4 (66.67) | 0.34 |
| III | 15 (53.57) | 5 (33.33) | 6 (40.00) | 4 (26.67) | |
| IV | 7 (25.00) | 2 (28.57) | 3 (42.86) | 2 (28.57) | |
| Lymph node Positive | 21 (75.00) | 6 (28.57) | 8 (38.10) | 7 (33.33) | 0.49 |
| invasion Negative | 7 (25.00) | 3 (42.86) | 1 (14.29) | 3 (42.86) | |